UY30556A1 - DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS - Google Patents

DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS

Info

Publication number
UY30556A1
UY30556A1 UY30556A UY30556A UY30556A1 UY 30556 A1 UY30556 A1 UY 30556A1 UY 30556 A UY30556 A UY 30556A UY 30556 A UY30556 A UY 30556A UY 30556 A1 UY30556 A1 UY 30556A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutically acceptable
methylmorfolin
pirido
pyrimidines
substitutes
Prior art date
Application number
UY30556A
Other languages
Spanish (es)
Inventor
Niall Morrisson Barr Martin
Murray Smith
Graeme Cameron
Frederic Georges Marie Leroux
Heather Mary Ellen Duggan
Karine Malagu
Menear Keith Allan
Original Assignee
Kudos Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kudos Pharm Ltd filed Critical Kudos Pharm Ltd
Priority to UY30556A priority Critical patent/UY30556A1/en
Publication of UY30556A1 publication Critical patent/UY30556A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona un compuesto un compuesto de formula I: o una sal farmacéuticamente aceptable del mismo. También se proporcionan procesos para la fabricacion de un compuesto de Formula I, y el uso de un compuesto de Formula I como medicamento para tratamiento del cáncer.A compound is provided a compound of formula I: or a pharmaceutically acceptable salt thereof. Processes are also provided for the manufacture of a Formula I compound, and the use of a Formula I compound as a medicament for cancer treatment.

UY30556A 2007-08-22 2007-08-22 DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS UY30556A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY30556A UY30556A1 (en) 2007-08-22 2007-08-22 DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY30556A UY30556A1 (en) 2007-08-22 2007-08-22 DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS

Publications (1)

Publication Number Publication Date
UY30556A1 true UY30556A1 (en) 2008-03-31

Family

ID=39247294

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30556A UY30556A1 (en) 2007-08-22 2007-08-22 DERIVATIVES 2, 7-SUBSTITUTES OF 4- (3-METHYLMORFOLIN-4-IL) PIRIDO [2,3-D] PYRIMIDINES AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS

Country Status (1)

Country Link
UY (1) UY30556A1 (en)

Similar Documents

Publication Publication Date Title
UY30819A1 (en) DERIVATIVES OF PIRAZOL, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
ECSP109935A (en) PYRIMIDINE MORFOLINE DERIVATIVES USED IN DISEASES RELATED TO MTOR QUINASA AND / OR PI3K
NI201000003A (en) TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
CR20150628A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
NI201000004A (en) TRISUSTITUED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
UY32462A (en) NEW BIFENYLL DERIVATIVES FOR HEPATITIS C 644 VIRUS INFECTION TREATMENT
SV2011004077A (en) AMINOBUTIRIC DERIVATIVES REPLACED AS NEPRILISINE INHIBITORS
UY30559A1 (en) DERIVATIVES OF MORFOLINO PIRIMIDINA, PREPARATION PROCESSES, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
ECSP10010419A (en) UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211
CO6480932A2 (en) ANTAGONISTS OF THE HEDGEHOG TRAJECTORY OF DISTTITUTED FTALAZINA.
EA201100971A1 (en) DERIVATIVES OF PYRIMIDININDOL FOR THE TREATMENT OF MALIGNANT NORMALIZATION
UY31254A1 (en) SUBSTITUTED DERIVATIVES OF N4- (5-METHYL-1H-PIRAZOL-3-IL) - 1,3,5-TRIAZINA-2,4-DIAMINE, THEIR ENANTIOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS, PREPARATION PROCESSES AND APPLICATIONS
ECSP088973A (en) IMIDAZOL PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE SYNTHETIC KINASE GLYCOGEN (GSK3)
UY30282A1 (en) CHEMICAL COMPOUNDS
UY30316A1 (en) SUBSTITUTED DERIVATIVES OF BENZAMIDS, NICOTINAMIDS, PROPANAMIDS, ACETAMIDS AND CARBOXAMIDS N- (2- (PIPERIDIN-1-ILMETIL) CICLOHEXIL) REPLACED, PREPARATION PROCESSES, COMPOSITIONS CONTAINING AND APPLICATIONS
NI200900183A (en) PYRID [2,3-D] PYRIMIDINE - 7 - ONA COMPOUNDS AS PI3K - ALPHA INHIBITORS FOR THE TREATMENT OF CANCER.
CY1114140T1 (en) 4-PYRIDINONE COMPONENTS AND THEIR USE FOR CANCER
UY31141A1 (en) PIPERIDINE COMPOUNDS AND ITS USES
CR11825A (en) UREA HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
UY32674A (en) UREA HETEROCICLICAL DERIVATIVES AND THEIR EMPLOYMENT METHODS
UY32055A (en) Substituted derivatives of 5-Halo-N2- [substituted] (1-methyl-1H-imidazol-4-yl) pyrimidin-2, -diamine and its pharmaceutically acceptable salts, preparation processes, compositions and applications.
UY31865A (en) HETEROCYCLIC UREA DERIVATIVES AND METHODS FOR THE USE OF THE SAME
CO6321280A2 (en) NEW ESPIRO PIPERIDINAS CLASS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
UY29134A1 (en) SULFONAMIDS REPLACED BY BENCIMIDAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN IT, PREPARATION PROCEDURE AND APPLICATIONS
PE20151607A1 (en) ORGANIC COMPOUND FORMULATIONS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170725